UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

Neuropsychopharmacology (New York, N.Y.), 2013-04, Vol.38 (5), p.729-742

2013

Volltextzugriff (PDF)

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists

Expert opinion on investigational drugs, 2014-02, Vol.23 (2), p.243-254

2014

Volltextzugriff (PDF)

Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive Disorder

Frontiers in psychiatry, 2017-05, Vol.8, p.89-89

2017

Volltextzugriff (PDF)

Comparison of the effects of antipsychotics on a delayed radial maze task in the rat

Psychopharmacologia, 2003-08, Vol.168 (4), p.410-416

2003

Volltextzugriff (PDF)

SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task

European journal of pharmacology, 2003-09, Vol.477 (3), p.213-217

2003

Volltextzugriff (PDF)

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without ketamine-like Side Effects

Neuropsychopharmacology (New York, N.Y.), 2013-06, Vol.38 (7), p.1374-1374

2013

Volltextzugriff (PDF)

Correction: GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without ketamine-like Side Effects

Neuropsychopharmacology (New York, N.Y.), 2013-06, Vol.38 (7), p.1374-1374

2013

Volltextzugriff (PDF)

Selective Serotonin Reuptake Inhibitors Decrease Impulsive Behavior as Measured by an Adjusting Delay Procedure in the Pigeon

Neuropsychopharmacology (New York, N.Y.), 2002-09, Vol.27 (3), p.421-429

2002

Volltextzugriff (PDF)

The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor

Journal of medicinal chemistry, 1988-07, Vol.31 (7), p.1412-1417

1988

Volltextzugriff (PDF)

Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents

Journal of medicinal chemistry, 1990-03, Vol.33 (3), p.895-902

1990

Volltextzugriff (PDF)

Behavioral pharmacology of olanzapine: a novel antipsychotic drug

The journal of clinical psychiatry, 1997, Vol.58 Suppl 10, p.37

1997

Volltextzugriff (PDF)

The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus

Neuroscience letters, 2000-10, Vol.293 (2), p.91-94

2000

Volltextzugriff (PDF)

Structure−Activity Studies of 6-(Tetrazolylalkyl)-Substituted Decahydroisoquinoline-3-carboxylic Acid AMPA Receptor Antagonists. 1. Effects of Stereochemistry, Chain Length, and Chain Substitution

Journal of medicinal chemistry, 1996-05, Vol.39 (11), p.2219-2231

1996

Volltextzugriff (PDF)

Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolines

Journal of medicinal chemistry, 1988-03, Vol.31 (3), p.555-560

1988

Volltextzugriff (PDF)

Anticonvulsant Properties of N‐Substituted α,α‐Diamino Acid Derivatives

Journal of pharmaceutical sciences, 1994-05, Vol.83 (5), p.689-691

1994

Volltextzugriff (PDF)

Increased food consumption by clozapine, but not by olanzapine, in satiated rats

Drug development research, 1997-05, Vol.41 (1), p.48-50

1997

Volltextzugriff (PDF)

The behavioral pharmacology of NMDA receptor antagonists

Trends in pharmacological sciences (Regular ed.), 1990-10, Vol.11 (10), p.423-428

1990

Volltextzugriff (PDF)

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine

The Journal of pharmacology and experimental therapeutics, 2000-08, Vol.294 (2), p.688

2000

Volltextzugriff (PDF)

Fluoxetine, a Selective Serotonin‐Uptake Inhibitor, Enhances the Anticonvulsant Effects of Phenytoin, Carbamazepine, and Ameltolide (LY 201116)

Epilepsia (Copenhagen), 1992-05, Vol.33 (3), p.573-576

Leander, J. David

1992

Volltextzugriff (PDF)

k-Opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist

Journal of pharmacy and pharmacology, 1984-08, Vol.36 (8), p.555-556

Leander, J. David

1984

Volltextzugriff (PDF)

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-Tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist

Journal of medicinal chemistry, 1993-07, Vol.36 (14), p.2046-2048

1993

Volltextzugriff (PDF)

Discovery of a Potent, Peripherally Selective trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonist for the Treatment of Gastrointestinal Motility Disorders

Journal of medicinal chemistry, 1994-07, Vol.37 (15), p.2262-2265

1994

Volltextzugriff (PDF)

Pharmacological Effects of Enantiomers of 4‐Amino‐N‐(α‐methylbenzyl)Benzamide, a Chemically Novel Anticonvulsant

Epilepsia (Copenhagen), 1988-01, Vol.29 (1), p.83-90

1988

Volltextzugriff (PDF)

Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazepine AMPA antagonists

Bioorganic & medicinal chemistry letters, 1999-07, Vol.9 (14), p.1953-1956

1999

Volltextzugriff (PDF)

Buprenorphine is a potent κ-opioid receptor antagonist in pigeons and mice

European journal of pharmacology, 1988-07, Vol.151 (3), p.457-461

Leander, J.David

1988

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(187)

Publikationsform

Sprache

Englisch
(217)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(148)
Animals
(106)
Male
(95)
Pharmacology & Pharmacy
(84)
Biological And Medical Sciences
(55)
Medical Sciences
(54)
Pharmacology. Drug Treatments
(49)
Mice
(48)
Neuropharmacology
(44)
Neurosciences & Neurology
(44)
Humans
(39)
Rats
(39)
Neurosciences
(38)
Chemistry, Medicinal
(33)
Columbidae
(33)
Dose-Response Relationship, Drug
(27)
Conditioning, Operant - Drug Effects
(24)
Chemistry
(22)
Behavioral Sciences
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists

Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive Disorder

Comparison of the effects of antipsychotics on a delayed radial maze task in the rat

SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task

GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without ketamine-like Side Effects

Correction: GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without ketamine-like Side Effects

Selective Serotonin Reuptake Inhibitors Decrease Impulsive Behavior as Measured by an Adjusting Delay Procedure in the Pigeon

The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor

Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents

Behavioral pharmacology of olanzapine: a novel antipsychotic drug

The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus

Structure−Activity Studies of 6-(Tetrazolylalkyl)-Substituted Decahydroisoquinoline-3-carboxylic Acid AMPA Receptor Antagonists. 1. Effects of Stereochemistry, Chain Length, and Chain Substitution

Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolines

Anticonvulsant Properties of N‐Substituted α,α‐Diamino Acid Derivatives

Increased food consumption by clozapine, but not by olanzapine, in satiated rats

The behavioral pharmacology of NMDA receptor antagonists

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine

Fluoxetine, a Selective Serotonin‐Uptake Inhibitor, Enhances the Anticonvulsant Effects of Phenytoin, Carbamazepine, and Ameltolide (LY 201116)

k-Opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist

(3SR,4aRS,6RS,8aRS)-6-[2-(1H-Tetrazol-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid: a structurally novel, systemically active, competitive AMPA receptor antagonist

Discovery of a Potent, Peripherally Selective trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonist for the Treatment of Gastrointestinal Motility Disorders

Pharmacological Effects of Enantiomers of 4‐Amino‐N‐(α‐methylbenzyl)Benzamide, a Chemically Novel Anticonvulsant

Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazepine AMPA antagonists

Buprenorphine is a potent κ-opioid receptor antagonist in pigeons and mice

Suchergebnisse filtern